查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1612861

宿主细胞污染物测试的全球市场：产业分析、规模、占有率、成长、趋势和预测（2024-2031）

Host Cell Contaminant Testing Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2031
出版日期: | 出版商: Persistence Market Research | 英文 198 Pages | 商品交期: 2-5个工作天内

价格
简介目录

重要见解

  • 宿主细胞污染物测试市场规模（2024年）：3.283亿美元
  • 市场规模预测（2031年）：4.788亿美元
  • 全球市场成长率（2024-2031）：复合年增长率5.5%

市场推动因素：

对高效宿主细胞污染物测试的需求主要是由生物製药品质保证日益增长的需求所推动的。随着产业的不断扩张，人们越来越关注确保产品的安全性、有效性和法规遵循。新一代定序和高解析度质谱等检测技术的进步透过提供准确可靠的结果进一步推动市场成长。此外，慢性病的增加和生物相似药的开发增加了严格的污染物测试方案的重要性。

市场阻碍因素：

儘管成长前景广阔，但市场仍面临一定的课题。与复杂的测试和设备相关的高成本可能是一个障碍，特别是对于小型企业和学术机构。此外，各地区的测试协议不标准化且不一致，影响了全球合规工作。这些因素可能会限制市场扩张，尤其是在成本效益非常高的新兴国家。

市场机会：

这个市场存在着巨大的机遇，特别是在污染物测试过程中自动化和人工智慧的整合方面。自动化系统不仅可以提高吞吐量，还可以最大限度地减少人为错误并确保更高的准确性。生物製药公司和合约研究组织之间的合作是另一种成长途径，可以有效利用资源并分享专业知识。此外，世界各地日益严格的法规预计将推动更先进、更全面的测试解决方案的采用。

本报告调查了全球宿主细胞污染物测试市场，并提供了市场的定义和概述、市场促进和阻碍因素、各种趋势、市场机会、课题、市场规模（数量和部分数量）的趋势，它总结了预测，各细分市场/地区/主要国家的详细分析、竞争环境、主要公司概况等。

目录

第1章执行摘要

第2章 市场概况

  • 市场定义
  • 市场分类

第3章宿主细胞污染物测试：市场机会分析

  • 宏观经济因素
  • 机会分析
  • 市场动态

第4章北美宿主细胞污染物测试市场分析与预测

  • 市场规模趋势/预测：按国家/地区划分
    • 美国
    • 加拿大
  • 市场规模趋势与预测：按产品类型
    • 基于 PCR 的检测
    • 基于 ELISA 的检测
  • 市场规模趋势与预测：按平台
    • 微生物
    • 哺乳动物的
    • 其他
  • 市场规模趋势与预测：按应用分类
    • 研究与开发
    • 临床应用
  • 市场规模趋势与预测：按最终用户分类
    • 生物製药公司
    • 合约研究组织
    • 奇美欧
    • 学术研究机构
  • 促进因素与抑制因素：影响分析
  • 市场吸引力分析
  • 主要进入者
  • 市场存在（实力图）

第5章拉丁美洲宿主细胞污染物测试市场分析与预测

  • 市场规模趋势/预测：按国家/地区划分
    • 巴西
    • 墨西哥
    • 其他
  • 市场规模趋势与预测：按产品类型
  • 市场规模趋势与预测：按平台
  • 市场规模趋势与预测：按应用分类
  • 市场规模趋势与预测：按最终用户分类
  • 促进因素与抑制因素：影响分析
  • 市场吸引力分析
  • 主要进入者
  • 市场存在（实力图）

第6章欧洲宿主细胞污染物测试市场分析与预测

  • 市场规模趋势/预测：按国家/地区划分
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他
  • 市场规模趋势与预测：按产品类型
  • 市场规模趋势与预测：按平台
  • 市场规模趋势与预测：按应用分类
  • 市场规模趋势与预测：按最终用户分类
  • 促进因素与抑制因素：影响分析
  • 市场吸引力分析
  • 主要进入者
  • 市场存在（实力图）

第7章亚太宿主细胞污染物测试市场分析与预测

  • 市场规模趋势/预测：按国家/地区划分
    • 中国
    • 日本
    • 印度
    • ASEAN
    • 澳大利亚/纽西兰
    • 其他
  • 市场规模趋势与预测：按产品类型
  • 市场规模趋势与预测：按平台
  • 市场规模趋势与预测：按应用分类
  • 市场规模趋势与预测：按最终用户分类
  • 促进因素与抑制因素：影响分析
  • 市场吸引力分析
  • 主要进入者
  • 市场存在（实力图）

第8章中东与非洲宿主细胞污染物测试市场分析与预测

  • 市场规模趋势/预测：按国家/地区划分
    • 海湾合作委员会国家
    • 南非
    • 北非
    • 其他
  • 市场规模趋势与预测：按产品类型
  • 市场规模趋势与预测：按平台
  • 市场规模趋势与预测：按应用分类
  • 市场规模趋势与预测：按最终用户分类
  • 促进因素与抑制因素：影响分析
  • 市场吸引力分析
  • 主要进入者
  • 市场存在（实力图）

第9章预测因子：相关性与影响

第10章预测的前提条件

第11章 竞争格局

  • 比赛仪表板
  • 公司简介（详细资料：概述、财务、策略、SWOT、近期趋势）
    • BioGenes GmbH
    • Bio-Rad Laboratories, Inc.
    • Cisbio Bioassays
    • Cygnus Technologies LLC (A Maravai Lifesciences Company)
    • Enzo Life Sciences, Inc.
    • ForteBio (A Pall Company)
    • GE Healthcare Life Sciences
    • Molecular Devices LLC
    • ProteinSimple (A BioTechne Brand)
    • Thermo Fisher Scientific, Inc.

第12章全球宿主细胞污染物测试市场分析及地区预测

第13章依产品类型划分的全球宿主细胞污染物测试市场分析与预测

第14章全球宿主细胞污染物测试市场分析与预测：依平台

第15章全球宿主细胞污染物测试市场分析与预测：依应用分类

第16章全球宿主细胞污染物测试市场分析与预测：依终端使用者分类

第17章全球宿主细胞污染物测试市场分析与预测

  • 市场规模/年成长率
  • 获利机会

第18章研究方法

简介目录
Product Code: PMRREP21355

Persistence Market Research has recently released a comprehensive report on the global host cell contaminant testing market, providing an in-depth analysis of key market dynamics, including driving forces, emerging trends, opportunities, and challenges. This report offers a detailed understanding of the market landscape, helping stakeholders make well-informed decisions.

Key Insights:

  • Host Cell Contaminant Testing Market Size (2024E): US$ 328.3 Mn
  • Projected Market Value (2031F): US$ 478.8 Mn
  • Global Market Growth Rate (CAGR 2024 to 2031): 5.5%

Host Cell Contaminant Testing Market - Report Scope:

Host cell proteins refer to a diverse group of proteins derived from host cells such as yeast, E. coli, and mammals. These proteins exhibit significant differences in properties, isoelectric points, and molecular masses. The identification and quantification of host cell contaminants are crucial during biopharmaceutical development. A wide array of techniques, including immuno-specific methods like ELISA, Western Blot, and PCR, as well as non-specific methods like electrophoresis and LC-MS, are utilized to ensure the purity of biopharmaceutical samples. The ideal approach combines high throughput and quantitative analysis to identify all types of contaminants effectively.

Market Drivers:

The demand for efficient host cell contaminant testing methods is primarily driven by the growing need for quality assurance in biopharmaceuticals. As the industry continues to expand, there is a heightened emphasis on ensuring the safety, efficacy, and regulatory compliance of products. Advances in detection technologies, such as next-generation sequencing and high-resolution mass spectrometry, further propel market growth by offering precise and reliable results. Additionally, the increasing prevalence of chronic diseases and the rise in biosimilar development are amplifying the importance of rigorous contaminant testing protocols.

Market Restraints:

Despite the promising growth prospects, the market faces certain challenges. High costs associated with advanced testing methods and equipment can act as barriers, especially for smaller companies and academic institutions. Furthermore, the lack of standardization in testing protocols across regions leads to inconsistencies, impacting global compliance efforts. These factors can limit market expansion, particularly in emerging economies where cost-effectiveness is a critical consideration.

Market Opportunities:

The market holds significant opportunities, particularly in the integration of automation and artificial intelligence in contaminant testing processes. Automated systems not only enhance throughput but also minimize human error, ensuring higher accuracy. Collaborations between biopharmaceutical companies and contract research organizations present another growth avenue, enabling efficient resource utilization and expertise sharing. Furthermore, increasing regulatory stringency worldwide is likely to drive the adoption of more advanced and comprehensive testing solutions.

Competitive Intelligence and Business Strategy:

The global host cell contaminant testing market is characterized by the presence of key players focusing on innovation, strategic collaborations, and geographic expansion. Leading companies are investing in research and development to offer cutting-edge solutions, ensuring precision and efficiency in contaminant detection. Partnerships between large-scale pharmaceutical firms and smaller biopharmaceutical entities are fostering market growth, enabling the introduction of novel testing methodologies.

.

Key Companies Profiled:

  • BioGenes GmbH
  • Bio-Rad Laboratories, Inc.
  • Cisbio Bioassays
  • Cygnus Technologies LLC (A Maravai Lifesciences Company)
  • Enzo Life Sciences, Inc.
  • ForteBio (A Pall Company)
  • GE Healthcare Life Sciences
  • Molecular Devices LLC
  • ProteinSimple (A BioTechne Brand)
  • Thermo Fisher Scientific, Inc.
  • Others

Host Cell Contaminant Testing Market Segmentation:

By Product Type:

  • PCR-based Assays
  • ELISA-based Assays

By Platform:

  • Microbial
  • Mammalian
  • Others

By Application:

  • Research & Development
  • Clinical Applications

By End User:

  • Biopharmaceutical Companies
  • Contract Research Organizations
  • Contract Manufacturing Organizations
  • Academic & Research Institutes

By Region:

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Market Overview
  • 1.2. Market Analysis
  • 1.3. PMR Analysis and Recommendations
  • 1.4. Wheel of Fortune

2. Market Introduction

  • 2.1. Market Definition
  • 2.2. Market Taxonomy

3. Host Cell Contaminant Testing Market Opportunity Analysis

  • 3.1. Macro-Economic Factors
  • 3.2. Opportunity Analysis
  • 3.3. Market Dynamics

4. North America Host Cell Contaminant Testing Market Analysis 2019 - 2023 and Forecast 2024 - 2031

  • 4.1. Introduction
  • 4.2. Historical Market Size (US$ Mn ) Trend Analysis By Country, 2019 - 2023
    • 4.2.1. U.S.
    • 4.2.2. Canada
  • 4.3. Market Size (US$ Mn ) Forecast By Country, 2024 - 2031
    • 4.3.1. U.S.
    • 4.3.2. Canada
  • 4.4. Historical Market Size (US$ Mn ) Trend Analysis By Product Type, 2019 - 2023
    • 4.4.1. PCR-based Assays
    • 4.4.2. ELISA-based Assays
  • 4.5. Market Size (US$ Mn ) Forecast By Product Type, 2024 - 2031
    • 4.5.1. PCR-based Assays
    • 4.5.2. ELISA-based Assays
  • 4.6. Historical Market Size (US$ Mn ) Trend Analysis By Platform, 2019 - 2023
    • 4.6.1. Microbial
    • 4.6.2. Mammalian
    • 4.6.3. Others
  • 4.7. Market Size (US$ Mn ) Forecast By Platform, 2024 - 2031
    • 4.7.1. Microbial
    • 4.7.2. Mammalian
    • 4.7.3. Others
  • 4.8. Historical Market Size (US$ Mn ) Trend Analysis By Application, 2019 - 2023
    • 4.8.1. Research & Development
    • 4.8.2. Clinical Applications
  • 4.9. Market Size (US$ Mn ) Forecast By Application, 2024 - 2031
    • 4.9.1. Research & Development
    • 4.9.2. Clinical Applications
  • 4.10. Historical Market Size (US$ Mn ) Trend Analysis By End User, 2019 - 2023
    • 4.10.1. Biopharmaceutical Companies
    • 4.10.2. Contract Research Organizations
    • 4.10.3. Contract Manufacturing Organizations
    • 4.10.4. Academic & Research Institutes
  • 4.11. Market Size (US$ Mn ) Forecast By End User, 2024 - 2031
    • 4.11.1. Biopharmaceutical Companies
    • 4.11.2. Contract Research Organizations
    • 4.11.3. Contract Manufacturing Organizations
    • 4.11.4. Academic & Research Institutes
  • 4.12. Drivers and Restraints: Impact Analysis
  • 4.13. Market Attractiveness Analysis
    • 4.13.1. By Country
    • 4.13.2. By Product Type
    • 4.13.3. By Platform
    • 4.13.4. By Application
    • 4.13.5. By End User
  • 4.14. Key Representative Market Participants
  • 4.15. Market Presence (Intensity Map)

5. Latin America Host Cell Contaminant Testing Market Analysis 2019 - 2023 and Forecast 2024 - 2031

  • 5.1. Introduction
  • 5.2. Historical Market Size (US$ Mn ) Trend Analysis By Country, 2019 - 2023
    • 5.2.1. Brazil
    • 5.2.2. Mexico
    • 5.2.3. Rest of Latin America
  • 5.3. Market Size (US$ Mn ) Forecast By Country, 2024 - 2031
    • 5.3.1. Brazil
    • 5.3.2. Mexico
    • 5.3.3. Rest of Latin America
  • 5.4. Historical Market Size (US$ Mn ) Trend Analysis By Product Type, 2019 - 2023
    • 5.4.1. PCR-based Assays
    • 5.4.2. ELISA-based Assays
  • 5.5. Market Size (US$ Mn ) Forecast By Product Type, 2024 - 2031
    • 5.5.1. PCR-based Assays
    • 5.5.2. ELISA-based Assays
  • 5.6. Historical Market Size (US$ Mn ) Trend Analysis By Platform, 2019 - 2023
    • 5.6.1. Microbial
    • 5.6.2. Mammalian
    • 5.6.3. Others
  • 5.7. Market Size (US$ Mn ) Forecast By Platform, 2024 - 2031
    • 5.7.1. Microbial
    • 5.7.2. Mammalian
    • 5.7.3. Others
  • 5.8. Historical Market Size (US$ Mn ) Trend Analysis By Application, 2019 - 2023
    • 5.8.1. Research & Development
    • 5.8.2. Clinical Applications
  • 5.9. Market Size (US$ Mn ) Forecast By Application, 2024 - 2031
    • 5.9.1. Research & Development
    • 5.9.2. Clinical Applications
  • 5.10. Historical Market Size (US$ Mn ) Trend Analysis By End User, 2019 - 2023
    • 5.10.1. Biopharmaceutical Companies
    • 5.10.2. Contract Research Organizations
    • 5.10.3. Contract Manufacturing Organizations
    • 5.10.4. Academic & Research Institutes
  • 5.11. Market Size (US$ Mn ) Forecast By End User, 2024 - 2031
    • 5.11.1. Biopharmaceutical Companies
    • 5.11.2. Contract Research Organizations
    • 5.11.3. Contract Manufacturing Organizations
    • 5.11.4. Academic & Research Institutes
  • 5.12. Drivers and Restraints: Impact Analysis
  • 5.13. Market Attractiveness Analysis
    • 5.13.1. By Country
    • 5.13.2. By Product Type
    • 5.13.3. By Platform
    • 5.13.4. By Application
    • 5.13.5. By End User
  • 5.14. Key Representative Market Participants
  • 5.15. Market Presence (Intensity Map)

6. Europe Host Cell Contaminant Testing Market Analysis 2019 - 2023 and Forecast 2024 - 2031

  • 6.1. Introduction
  • 6.2. Historical Market Size (US$ Mn ) Trend Analysis By Country, 2019 - 2023
    • 6.2.1. Germany
    • 6.2.2. U.K.
    • 6.2.3. France
    • 6.2.4. Italy
    • 6.2.5. Spain
    • 6.2.6. Russia
    • 6.2.7. Rest of Europe
  • 6.3. Market Size (US$ Mn ) Forecast By Country, 2024 - 2031
    • 6.3.1. Germany
    • 6.3.2. U.K.
    • 6.3.3. France
    • 6.3.4. Italy
    • 6.3.5. Spain
    • 6.3.6. Russia
    • 6.3.7. Rest of Europe
  • 6.4. Historical Market Size (US$ Mn ) Trend Analysis By Product Type, 2019 - 2023
    • 6.4.1. PCR-based Assays
    • 6.4.2. ELISA-based Assays
  • 6.5. Market Size (US$ Mn ) Forecast By Product Type, 2024 - 2031
    • 6.5.1. PCR-based Assays
    • 6.5.2. ELISA-based Assays
  • 6.6. Historical Market Size (US$ Mn ) Trend Analysis By Platform, 2019 - 2023
    • 6.6.1. Microbial
    • 6.6.2. Mammalian
    • 6.6.3. Others
  • 6.7. Market Size (US$ Mn ) Forecast By Platform, 2024 - 2031
    • 6.7.1. Microbial
    • 6.7.2. Mammalian
    • 6.7.3. Others
  • 6.8. Historical Market Size (US$ Mn ) Trend Analysis By Application, 2019 - 2023
    • 6.8.1. Research & Development
    • 6.8.2. Clinical Applications
  • 6.9. Market Size (US$ Mn ) Forecast By Application, 2024 - 2031
    • 6.9.1. Research & Development
    • 6.9.2. Clinical Applications
  • 6.10. Historical Market Size (US$ Mn ) Trend Analysis By End User, 2019 - 2023
    • 6.10.1. Biopharmaceutical Companies
    • 6.10.2. Contract Research Organizations
    • 6.10.3. Contract Manufacturing Organizations
    • 6.10.4. Academic & Research Institutes
  • 6.11. Market Size (US$ Mn ) Forecast By End User, 2024 - 2031
    • 6.11.1. Biopharmaceutical Companies
    • 6.11.2. Contract Research Organizations
    • 6.11.3. Contract Manufacturing Organizations
    • 6.11.4. Academic & Research Institutes
  • 6.12. Drivers and Restraints: Impact Analysis
  • 6.13. Market Attractiveness Analysis
    • 6.13.1. By Country
    • 6.13.2. By Product Type
    • 6.13.3. By Platform
    • 6.13.4. By Application
    • 6.13.5. By End User
  • 6.14. Key Representative Market Participants
  • 6.15. Market Presence (Intensity Map)

7. Asia Pacific Host Cell Contaminant Testing Market Analysis 2019 - 2023 and Forecast 2024 - 2031

  • 7.1. Introduction
  • 7.2. Historical Market Size (US$ Mn ) Trend Analysis By Country, 2019 - 2023
    • 7.2.1. China
    • 7.2.2. Japan
    • 7.2.3. India
    • 7.2.4. ASEAN
    • 7.2.5. Australia and New Zealand
    • 7.2.6. Rest of Asia Pacific
  • 7.3. Market Size (US$ Mn ) Forecast By Country, 2024 - 2031
    • 7.3.1. China
    • 7.3.2. Japan
    • 7.3.3. India
    • 7.3.4. ASEAN
    • 7.3.5. Australia and New Zealand
    • 7.3.6. Rest of Asia Pacific
  • 7.4. Historical Market Size (US$ Mn ) Trend Analysis By Product Type, 2019 - 2023
    • 7.4.1. PCR-based Assays
    • 7.4.2. ELISA-based Assays
  • 7.5. Market Size (US$ Mn ) Forecast By Product Type, 2024 - 2031
    • 7.5.1. PCR-based Assays
    • 7.5.2. ELISA-based Assays
  • 7.6. Historical Market Size (US$ Mn ) Trend Analysis By Platform, 2019 - 2023
    • 7.6.1. Microbial
    • 7.6.2. Mammalian
    • 7.6.3. Others
  • 7.7. Market Size (US$ Mn ) Forecast By Platform, 2024 - 2031
    • 7.7.1. Microbial
    • 7.7.2. Mammalian
    • 7.7.3. Others
  • 7.8. Historical Market Size (US$ Mn ) Trend Analysis By Application, 2019 - 2023
    • 7.8.1. Research & Development
    • 7.8.2. Clinical Applications
  • 7.9. Market Size (US$ Mn ) Forecast By Application, 2024 - 2031
    • 7.9.1. Research & Development
    • 7.9.2. Clinical Applications
  • 7.10. Historical Market Size (US$ Mn ) Trend Analysis By End User, 2019 - 2023
    • 7.10.1. Biopharmaceutical Companies
    • 7.10.2. Contract Research Organizations
    • 7.10.3. Contract Manufacturing Organizations
    • 7.10.4. Academic & Research Institutes
  • 7.11. Market Size (US$ Mn ) Forecast By End User, 2024 - 2031
    • 7.11.1. Biopharmaceutical Companies
    • 7.11.2. Contract Research Organizations
    • 7.11.3. Contract Manufacturing Organizations
    • 7.11.4. Academic & Research Institutes
  • 7.12. Drivers and Restraints: Impact Analysis
  • 7.13. Market Attractiveness Analysis
    • 7.13.1. By Country
    • 7.13.2. By Product Type
    • 7.13.3. By Platform
    • 7.13.4. By Application
    • 7.13.5. By End User
  • 7.14. Key Representative Market Participants
  • 7.15. Market Presence (Intensity Map)

8. Middle East & Africa Host Cell Contaminant Testing Market Analysis 2019 - 2023 and Forecast 2024 - 2031

  • 8.1. Introduction
  • 8.2. Historical Market Size (US$ Mn ) Trend Analysis By Country, 2019 - 2023
    • 8.2.1. GCC Countries
    • 8.2.2. South Africa
    • 8.2.3. North Africa
    • 8.2.4. Rest of MEA
  • 8.3. Market Size (US$ Mn ) Forecast By Country, 2024 - 2031
    • 8.3.1. GCC Countries
    • 8.3.2. South Africa
    • 8.3.3. North Africa
    • 8.3.4. Rest of MEA
  • 8.4. Historical Market Size (US$ Mn ) Trend Analysis By Product Type, 2019 - 2023
    • 8.4.1. PCR-based Assays
    • 8.4.2. ELISA-based Assays
  • 8.5. Market Size (US$ Mn ) Forecast By Product Type, 2024 - 2031
    • 8.5.1. PCR-based Assays
    • 8.5.2. ELISA-based Assays
  • 8.6. Historical Market Size (US$ Mn ) Trend Analysis By Platform, 2019 - 2023
    • 8.6.1. Microbial
    • 8.6.2. Mammalian
    • 8.6.3. Others
  • 8.7. Market Size (US$ Mn ) Forecast By Platform, 2024 - 2031
    • 8.7.1. Microbial
    • 8.7.2. Mammalian
    • 8.7.3. Others
  • 8.8. Historical Market Size (US$ Mn ) Trend Analysis By Application, 2019 - 2023
    • 8.8.1. Research & Development
    • 8.8.2. Clinical Applications
  • 8.9. Market Size (US$ Mn ) Forecast By Application, 2024 - 2031
    • 8.9.1. Research & Development
    • 8.9.2. Clinical Applications
  • 8.10. Historical Market Size (US$ Mn ) Trend Analysis By End User, 2019 - 2023
    • 8.10.1. Biopharmaceutical Companies
    • 8.10.2. Contract Research Organizations
    • 8.10.3. Contract Manufacturing Organizations
    • 8.10.4. Academic & Research Institutes
  • 8.11. Market Size (US$ Mn ) Forecast By End User, 2024 - 2031
    • 8.11.1. Biopharmaceutical Companies
    • 8.11.2. Contract Research Organizations
    • 8.11.3. Contract Manufacturing Organizations
    • 8.11.4. Academic & Research Institutes
  • 8.12. Drivers and Restraints: Impact Analysis
  • 8.13. Market Attractiveness Analysis
    • 8.13.1. By Country
    • 8.13.2. By Product Type
    • 8.13.3. By Platform
    • 8.13.4. By Application
    • 8.13.5. By End User
  • 8.14. Key Representative Market Participants
  • 8.15. Market Presence (Intensity Map)

9. Forecast Factors: Relevance and Impact

10. Forecast Assumptions

11. Competition Landscape

  • 11.1. Competition Dashboard
  • 11.2. Company Profiles (Details - Overview, Financials, Strategy, SWOT, Recent Developments)
    • 11.2.1. BioGenes GmbH
    • 11.2.2. Bio-Rad Laboratories, Inc.
    • 11.2.3. Cisbio Bioassays
    • 11.2.4. Cygnus Technologies LLC (A Maravai Lifesciences Company)
    • 11.2.5. Enzo Life Sciences, Inc.
    • 11.2.6. ForteBio (A Pall Company)
    • 11.2.7. GE Healthcare Life Sciences
    • 11.2.8. Molecular Devices LLC
    • 11.2.9. ProteinSimple (A BioTechne Brand)
    • 11.2.10. Thermo Fisher Scientific, Inc.

12. Global Host Cell Contaminant Testing Market Analysis 2019 - 2023 and Forecast 2024 - 2031, By Region

  • 12.1. Introduction/Key Findings
  • 12.2. Historical Market Size (US$ Mn ) Trend Analysis By Region, 2019 - 2023
    • 12.2.1. North America
    • 12.2.2. Latin America
    • 12.2.3. Europe
    • 12.2.4. Asia Pacific
    • 12.2.5. Middle East & Africa
  • 12.3. Market Size (US$ Mn ) Forecast By Region, 2024 - 2031
    • 12.3.1. North America
    • 12.3.2. Latin America
    • 12.3.3. Europe
    • 12.3.4. Asia Pacific
    • 12.3.5. Middle East & Africa
  • 12.4. Market Attractiveness Analysis By Region

13. Global Host Cell Contaminant Testing Market Analysis 2019 - 2023 and Forecast 2024 - 2031, By Product Type

  • 13.1. Introduction/Key Findings
  • 13.2. Historical Market Size (US$ Mn ) Trend Analysis By Product Type, 2019 - 2023
    • 13.2.1. PCR-based Assays
    • 13.2.2. ELISA-based Assays
  • 13.3. Market Size (US$ Mn ) Forecast By Product Type, 2024 - 2031
    • 13.3.1. PCR-based Assays
    • 13.3.2. ELISA-based Assays
  • 13.4. Market Attractiveness Analysis By Product Type

14. Global Host Cell Contaminant Testing Market Analysis 2019 - 2023 and Forecast 2024 - 2031, By Platform

  • 14.1. Introduction/Key Findings
  • 14.2. Historical Market Size (US$ Mn ) Trend Analysis By Platform, 2019 - 2023
    • 14.2.1. Microbial
    • 14.2.2. Mammalian
    • 14.2.3. Others
  • 14.3. Market Size (US$ Mn ) Forecast By Platform, 2024 - 2031
    • 14.3.1. Microbial
    • 14.3.2. Mammalian
    • 14.3.3. Others
  • 14.4. Market Attractiveness Analysis By Platform

15. Global Host Cell Contaminant Testing Market Analysis 2019 - 2023 and Forecast 2024 - 2031, By Application

  • 15.1. Introduction/Key Findings
  • 15.2. Historical Market Size (US$ Mn ) Trend Analysis By Application, 2019 - 2023
    • 15.2.1. Research & Development
    • 15.2.2. Clinical Applications
  • 15.3. Market Size (US$ Mn ) Forecast By Application, 2024 - 2031
    • 15.3.1. Research & Development
    • 15.3.2. Clinical Applications
  • 15.4. Market Attractiveness Analysis By Application

16. Global Host Cell Contaminant Testing Market Analysis 2019 - 2023 and Forecast 2024 - 2031, By End User

  • 16.1.Introduction/Key Findings
  • 16.2. Historical Market Size (US$ Mn ) Trend Analysis By End User, 2019 - 2023
    • 16.2.1. Biopharmaceutical Companies
    • 16.2.2. Contract Research Organizations
    • 16.2.3. Contract Manufacturing Organizations
    • 16.2.4. Academic & Research Institutes
  • 16.3. Market Size (US$ Mn ) Forecast By End User, 2024 - 2031
    • 16.3.1. Biopharmaceutical Companies
    • 16.3.2. Contract Research Organizations
    • 16.3.3. Contract Manufacturing Organizations
    • 16.3.4. Academic & Research Institutes
  • 16.4. Market Attractiveness Analysis By End User

17. Global Host Cell Contaminant Testing Market Analysis 2019 - 2023 and Forecast 2024 - 2031

  • 17.1. Market Size and Y-o-Y Growth
  • 17.2. Absolute $ Opportunity

18. Research Methodology